What is the size of the Digital Biomarkers market in 2023?

The Digital Biomarkers market size is USD 3.4 Billion in 2023.

What is the projected CAGR at which the Digital Biomarkers market is expected to grow at?

The Digital Biomarkers market is expected to grow at a CAGR of 21.7% (2024-2033).

List the segments encompassed in this report on the Digital Biomarkers market?

Market.US has segmented the Digital Biomarkers market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Type the market has been segmented into Wearables, Mobile based Applications, Sensors, Other Types. By Clinical Practice the market has been segmented into Monitoring Digital Biomarkers, Diagnostic Digital Biomarkers, Predictive and Prognostic Digital Biomarkers, Other Clinical Practices. By Application the market has been segmented into Cardiovascular and Metabolic Disorders, Respiratory Disorders, Neurological Disorders, Musculoskeletal Disorders, Psychiatric Disorders, Other Applications. By End-User the market has been segmented into Pharmaceutical Companies, Healthcare Providers, Payers, Other End-Users.

List the key industry players of the Digital Biomarkers market?

F. Hoffmann-La Roche Ltd., ActiGraph, Koneksa, Altoida Inc., Adherium Limited, Neurotrack Technologies Inc., Biogen Inc., Empatica Inc., Fitbit Health Solutions, AliveCor Inc., Aural Analytic, Other Key Players

Which region is more appealing for vendors employed in the Digital Biomarkers market?

North America is expected to account for the highest revenue share of 55.2% and boasting an impressive market value of USD 1.87 Billion. Therefore, the Digital Biomarkers industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Digital Biomarkers?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Digital Biomarkers Market.

Global Digital Biomarkers Market by Type (Wearables, Sensors, and Other Types), By Clinical Practice (Monitoring Digital Biomarkers, and Other Clinical Practices), By Application, By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032

Published date: Feb 2024
Report ID: 102145
Number of Pages: 204
Format:

- F. Hoffmann-La Roche Ltd.
- ActiGraph
- Koneksa
- Altoida Inc.
- Adherium Limited
- Neurotrack Technologies, Inc.
- Biogen Inc.
- Empatica Inc.
- Fitbit Health Solutions
- AliveCor Inc.
- Aural Analytic
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 102145
Published Date Feb 2024
Rating
- ★★★★★
  
  ★★★★★
- (119)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)